Cargando…
Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
In patients with active acromegaly after pituitary surgery, somatostatin analogues are effective in controlling the disease and can even be curative in some cases. After treatment discontinuation, the likelihood of disease recurrence is high. However, a small subset of patients remains symptom-free...
Autores principales: | Alvarez-Escola, Cristina, Cardenas-Salas, Jersy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118967/ https://www.ncbi.nlm.nih.gov/pubmed/27933171 http://dx.doi.org/10.1530/EDM-16-0092 |
Ejemplares similares
-
Improved AcroQoL scores in acromegaly after sagittal split ramus osteotomy with Le Fort I osteotomy
por: Taguchi, Tomomi, et al.
Publicado: (2021) -
Advanced acromegaly: successful disease control for more than 16 years using octreotide LA
por: Elshafie, Omayma, et al.
Publicado: (2020) -
Rapid pleural effusion after discontinuation of lenvatinib in a patient with pleural metastasis from thyroid cancer
por: Uchida, Taisuke, et al.
Publicado: (2019) -
One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin
por: Lima-Martínez, Marcos M, et al.
Publicado: (2014) -
Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2016)